Owner Scorecard


← All companies ← CLOV Manual CLS → ← CERS Medical Devices & Equipment CNMD →

CLPT, ClearPoint Neuro Inc.

Medical Devices & Equipment consumer brand UnprofitableDistress / turnaround

A medical-device business, placing equipment that pulls consumables and service behind it.

From our inception in 1998, we have deployed significant resources to fund our efforts to develop the foundational capabilities for enabling magnetic resonance imaging ("MRI") guided interventions, building an intellectual property portfolio, and identifying and building out commercial applications for the technologies we develop.

In 2021, our efforts expanded beyond the MRI suite to encompass development and commercialization of neurosurgical device products for the operating room setting, as well as consulting services for pharmaceutical companies.

Latest annual: FY2025 10-K
CLPT · ClearPoint Neuro Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$37M
+17.8% YoY · 24% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $42M 5-yr avg $26M
Gross margin 63% 5-yr avg 63%
Operating margin −73.4% 5-yr avg −76.7%
ROIC −77% 5-yr avg −176%
Owner-earnings margin −73% 5-yr avg −63%
Free cash flow margin −74% 5-yr avg −63%

Next report By 11/13 · the 10-Q for the quarter ended late September · due within 45 days of period end · has filed ~43 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Unprofitable. No meaningful revenue yet; the record is the cash on hand against the burn. Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock.
What moves the needle
Operating margin has run around −75% through the cycle on a 63% gross margin, the operating line in the red even at its best — so the lever is whether the spending below the gross line can come down enough to clear a profit: revenue growth against the cost curve, and the cash runway until it does. Inventory runs near 29% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −228%, above 15% in 0 of 10 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$6M$7M$7M$11M$13M$16M$21M$24M$31M$37M$42MRevenueRevenue
$3M$4M$5M$7M$9M$11M$14M$14M$19M$23M$26MGross profitGross prof.
54%61%67%65%71%68%66%57%61%61%63%Gross marginGross mgn
73%55%59%38%41%49%47%49%38%45%46%SG&A / revenueSG&A/rev
46%38%31%25%37%57%53%49%39%38%37%R&D / revenueR&D/rev
($7M)($6M)($5M)($5M)($6M)($13M)($16M)($22M)($20M)($24M)($31M)Operating incomeOp. inc.
−130.3%−85.9%−71.4%−41.0%−48.5%−82.1%−79.5%−93.7%−62.9%−65.4%−73.4%Operating marginOp. mgn
($8M)($7M)($6M)($6M)($7M)($14M)($16M)($22M)($19M)($26M)($35M)Net incomeNet inc.
Cash flow & returns
($6M)($6M)($5M)($3M)($8M)($13M)($16M)($14M)($9M)($24M)($30M)Operating cash flowOp. cash
$156K$116K$109K$144K$334K$159K$244K$626K$980K$814K$551KDepreciation & amortizationD&A
$907K($187K)$192K$2M($2M)($524K)($4M)$2M$2M($7M)($5M)Working capital & otherWC & other
$101K$27K$63K$10K$41K$168K$253K$717K$275K$522K$1MCapexCapex
1.8%0.4%0.9%0.1%0.3%1.0%1.2%3.0%0.9%1.4%2.6%Capex / revenueCapex/rev
($6M)($6M)($5M)($3M)($8M)($13M)($16M)($14M)($9M)($24M)($31M)Owner earningsOwner earn.
−103.0%−81.6%−63.8%−25.5%−61.2%−78.9%−79.9%−60.3%−29.4%−66.1%−72.6%Owner earnings marginOE mgn
($6M)($6M)($5M)($3M)($8M)($13M)($16M)($14M)($9M)($24M)($31M)Free cash flowFCF
−103.0%−81.6%−63.8%−25.5%−61.2%−78.9%−79.9%−60.3%−29.4%−66.1%−73.9%Free cash flow marginFCF mgn
($101K)($27K)($63K)($160K)($482K)($168K)($11M)$9M($275K)$615KInvesting cash flowInv. cash
$4M$12M($1M)$6M$23M$47M$409K$296K$6M$50MFinancing cash flowFin. cash
($2M)$6M($6M)$3M$14M$34M($26M)($4M)($3M)$27MChange in cashΔ cash
-1409%-344%-219%-377%-138%-234%-67%-222%-295%-61%-77%ROICROIC
-123%-408%-121%-285%-30%-45%-104%-74%-91%-321%Return on equityROE
−123%−408%−121%−285%−30%−45%−104%−74%−91%−321%Retained to equityRetained/eq
Balance sheet
$3M$9M$3M$6M$20M$54M$37M$23M$20M$46M$29MCash & investmentsCash+inv
$866K$949K$1M$1M$2M$2M$3M$3M$5M$7M$8MReceivablesReceiv.
$2M$2M$2M$3M$3M$5M$9M$8M$7M$8M$9MInventoryInvent.
$2M$759K$501K$966K$300K$427K$272K$393K$1M$1M$2MAccounts payablePayables
$1M$3M$3M$3M$5M$7M$12M$11M$10M$14M$15MOperating working capitalOper. WC
$6M$13M$7M$10M$25M$62M$51M$36M$33M$64M$49MCurrent assetsCur. assets
$3M$4M$2M$4M$3M$5M$7M$7M$10M$11M$10MCurrent liabilitiesCur. liab.
2.0×2.9×3.6×2.7×8.0×13.0×7.5×4.9×3.2×5.9×4.7×Current ratioCurr. ratio
$328K$268K$378K$447K$319K$539K$806K$1M$2M$3MNet PP&ENet PP&E
$0$7M$7MGoodwillGoodwill
$7M$14M$8M$12M$30M$66M$55M$43M$39M$98M$87MTotal assetsAssets
$4M$5M$3M$2M$21M$10M$10M$10M$0$49M$50MTotal debtDebt
$1M($4M)$380K($4M)$1M($44M)($28M)($13M)($20M)$3M$21MNet debt / (cash)Net debt
-7.1×-7.3×-5.4×-4.8×-4.3×-13.7×-201.6×-38.1×-10.1×-6.4×Interest coverageInt. cov.
$8M$8M$6M$7M$27M$17M$19M$21M$14M$70MTotal liabilitiesTotal liab.
($756K)$6M$2M$5M$2M$49M$37M$21M$25M$28M$11MShareholders’ equityEquity
20.6%16.9%16.7%7.1%8.5%12.7%20.1%25.4%22.0%22.1%20.1%Stock comp / revenueSBC/rev
Per share
8.3M7.7M10.9M13.2M15.8M20.7M24.2M24.6M27.0M28.3M29.9MShares out (diluted)Shares
$0.70$0.95$0.67$0.85$0.81$0.79$0.85$0.97$1.16$1.31$1.42Revenue / shareRev/sh
$-0.98$-0.93$-0.56$-0.42$-0.43$-0.69$-0.68$-0.90$-0.70$-0.90$-1.16EPS (diluted)EPS
$-0.72$-0.78$-0.43$-0.22$-0.50$-0.62$-0.68$-0.59$-0.34$-0.86$-1.03Owner earnings / shareOE/sh
$-0.72$-0.78$-0.43$-0.22$-0.50$-0.62$-0.68$-0.59$-0.34$-0.86$-1.05Free cash flow / shareFCF/sh
$0.01$0.00$0.01$0.00$0.00$0.01$0.01$0.03$0.01$0.02$0.04Cap. spending / shareCapex/sh
$-0.09$0.75$0.14$0.35$0.15$2.35$1.53$0.86$0.94$0.99$0.36Book value / shareBVPS

Share counts before 2017 are restated ×3 for a stock split, so per-share figures sit on one basis.

The diluted share count moved ×1.41 into 2018 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+7.2%/yr+10.0%/yr
Capital spending / share+4.7%/yr+48.1%/yr
Book value / share+45.8%/yr

The year, in the company's words

the filing →

Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.

  • Revenue+17.8%
    “Total revenue $ 36,971 $ 31,390 18 % Biologics and drug delivery revenue, which include sales of disposable products and services related to customer-sponsored preclinical and clinical trials utilizing our products, increased 10% to $19.0 million for the year ended December 31, 2025, from $17.3 million for the year ended December 31, 2024. This increase is attributable to $1.7 million of higher product revenue resulting from greater demand for disposables as multiple partners progress in their trials.”
    ✓ figure matches the filed record

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $26M loss into ($24M) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2025FY2024FY2023FY2022FY2021
Reported net income($26M)($19M)($22M)($16M)($14M)
Depreciation & amortizationnon-cash charge added back+$814K+$980K+$626K+$244K+$159K
Stock-based compensationreal costnon-cash, but a real cost+$8M+$7M+$6M+$4M+$2M
Working capital & othertiming of cash in and out, other non-cash items−$7M+$2M+$2M−$4M−$524K
Cash from operations($24M)($9M)($14M)($16M)($13M)
Capital expenditurecash put back in to keep running and to grow−$522K−$275K−$717K−$253K−$168K
Owner earnings($24M)($9M)($14M)($16M)($13M)
Owner-earnings marginowner earnings ÷ revenue-66%-29%-60%-80%-79%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $8M), owner earnings is nearer ($33M).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Does not cover its interest
    Operating income ($24M) ÷ interest expense $2M
    What this means

    A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.

  • Net debt against an operating loss
    Cash $46M − debt $49M
    What this means

    Netting $46M of cash and short-term investments against $49M of debt leaves $3M owed, with no operating profit this year to measure it against — understand that combination before anything else about the company. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 65 + DIO 214 − DPO 32 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Below average through the cycle
    10-yr median, range -1409%–-61%; -61% latest = NOPAT ($19M) ÷ invested capital $31M
    Industry peers: median -86%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran -61% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Consumes cash through the cycle
    10-yr median margin, range -103%–-25%; latest ($24M) = operating cash ($24M) − maintenance capex $522K
    Industry peers: median -67%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -66% of revenue this year, a -65% median across 10 years. Treating stock comp as the real expense it is (less $8M of SBC) leaves ($33M).

  • Loss, and burning cash
    Net income ($26M) · cash from operations ($24M)
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.64×
    Harvesting
    Capex $522K ÷ depreciation & amortization as filed $814K
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Heavy selling cost
    Selling and marketing $16M ÷ revenue $37M
    What this means

    Sales and marketing as a share of revenue, kept apart from administrative overhead because it answers a different question: how much a business must spend to win the next customer. A company whose product pulls customers in spends little here and keeps the difference; one that must buy its growth is running to stand still, and the spending has to keep rising for revenue to keep rising. Read it beside the growth rate, not alone.

  • Is the buyback buying ownership, or mopping up? 22.1%
    The count is rising
    Stock compensation $8M (fiscal 2025), 22.1% of revenue · no repurchases · diluted shares +17.1% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 2 of 4 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $37M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 5.91×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $49M vs $53M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (10-yr record) · 10 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.73/share (latest year $-0.84), the averaged base the calculator's gate runs on, and book value is $0.92/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 0 of 10
    What this means

    Lost money in 10 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin −96% → −74% (3-yr avg ends)
    What this means

    Through the cycle the operating margin widened — about −96% early to −74% lately, median −79% — pricing power intact or improving.

  • Reinvestment, incremental ROIC
    What this means

    The reinvested base moved too little against the change in profit to read a reliable return on it here — the figure would be a small-denominator artifact, not a moat. Judge this one on the owner-earnings record and the cash it returns instead.

  • Worst year 2016 · −130.3% op. margin
    What this means

    Operations went underwater in 2016, understand why before trusting the good years.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$49M
  • Cash & short-term investments$29M
  • Receivables$8M
  • Inventory$9M
  • Other current assets$2M
Current liabilities$10M
  • Accounts payable$2M
  • Other current liabilities$8M
Current ratio4.74×all current assets ÷ what's due · Graham looked for 2×
Quick ratio3.89×stricter: inventory excluded
Cash ratio2.85×strictest: cash alone against what's due
Working capital$39Mthe cushion left after near-term bills
Cash runway0.9 yrsthe business is consuming cash; this is how long the cash on hand lasts at that rate
Revenue, latest quarter vs. a year ago+18.1%the freshest read on whether the business is still growing
Current ratio, recent quarters4.5× → 4.7×
Deeper floors
Tangible book value($10M)equity stripped of goodwill & intangibles
Net current asset value($27M)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$64M$14M of it operating leases
Deferred revenue$2Mcustomer cash collected before delivery; operating float

From the company's latest filing.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$21M22% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity27%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$0over 10 years buying other businesses, against $2M of capital spent building over the 10-year record

None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend summed across the company's full tagged history, write-downs across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2023Mr. Burnett$2.0M$1.5M($14M)
2024Mr. Burnett$2.5M$5.9M($9M)
2025Mr. Burnett$2.8M$2.1M($24M)

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership6.9%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$8M

    The slice of the business handed to employees in shares in fiscal 2025, 22.1% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Inventory, Acquisitions, Stock compensation as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
DCTHDelcath Systems Inc.$85M81%-33.4%-127%-51%
SIShoulder Innovations Inc.$47M77%2y-51.0%2y-16%1y-59%2y
BWAYBrainsWay Ltd.$46M77%-26.5%-143%-26%
SSIISS Innovations International Inc.$42M27%-149.0%-86%-156%
CLPTClearPoint Neuro Inc.$37M63%-75.4%-228%-65%
BDMDBaird Medical Investment Holdings Limited$23M85%38.3%27%-14%
DRIODarioHealth Corp.$22M33%-257.7%-83%-192%
PROFProfound Medical Corp.$16M66%-309.6%-257%-238%1y
Group median71%-63.2%-106%-62%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

ClearPoint Neuro Inc. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Revenue, delivered24%/yr’20→’25

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−74%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "ClearPoint Neuro Inc. (CLPT), the owner's record," https://ownerscorecard.com/c/CLPT, data as of 2026-08-17.

Manual order: ← CLOV its page in the Manual CLS →

Industry order: ← CERS the Medical Devices & Equipment chapter CNMD →